glp 1 agonist function GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease Cardiovascular effects of Glucagon-like peptide
Description
Some patients may benefit from transitioning to lower doses of GLP-1 medications rather than complete discontinuation, though this approach requires further research to establish optimal dosing strategies
Front Cell Infect Microbiol 2021;11:595575.ArticlePubMedPMC 97
Humphrey CD, Lawrence AC
These may be symptoms of gastroparesis (stomach paralysis)
K., Lingvay, I., Macura, S.,
